Spatial navigation and APOE in amnestic mild cognitive impairment

Neurodegenerative Diseases

Volumn 8, Issue 4, 2011, Pages 169-177

  Laczó, Jan ^a,d   Andel, Ross ^e   Vlček, Kamil ^b   Mat'oška, Václav ^c   Vyhnálek, Martin ^a,d   Tolar, Martin ^f   Bojar, Martin ^a   Hort, Jakub ^a,d  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF PHYSIOLOGY   (Czech Republic)

^c NA HOMOLCE HOSPITAL   (Czech Republic)

^d International Clinical Research Center   (Czech Republic)

^e UNIVERSITY OF SOUTH FLORIDA   (United States)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Apolipoprotein E; Memory; Mild cognitive impairment; Morris water maze; Spatial navigation

Indexed keywords

APOLIPOPROTEIN E4;

AGED; AMNESTIC MILD COGNITIVE IMPAIRMENT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; HUMAN; LEARNING; MALE; MAZE TEST; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SPATIAL MEMORY; TASK PERFORMANCE;

ALZHEIMER DISEASE; AMNESIA; APOLIPOPROTEIN E4; COGNITION DISORDERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEUROPSYCHOLOGICAL TESTS; ORIENTATION; SPACE PERCEPTION;

EID: 79955849223     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000321581     Document Type: Article

References (43)

1. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA: Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261: 921-923. (Pubitemid 23275809)
2. Saunders AM, Hulette O, Welsh-Bohmer KA, Schmechel DE, Crain B, Burke JR, Alberts MJ, Strittmatter WJ, Breitner JC, Rosenberg C: Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease. Lancet 1996; 348: 90-93. (Pubitemid 26234356)
3. Bondi MW, Salmon DP, Monsch AU, Galasko D, Butters N, Klauber MR, Thal LJ, Saitoh T: Episodic memory changes are associated with the APOE-e4 allele in nondemented older adults. Neurology 1995; 45: 2203-2206. (Pubitemid 27100249)
4. Caselli RJ, Reiman EM, Osborne D, Hentz JG, Baxter LC, Hernandez JL, Alexander GG: Longitudinal changes in cognition and behavior in asymptomatic carriers of the APOE e4 allele. Neurology 2004; 62: 1990-1995. (Pubitemid 38738209)
5. Petersen RC, Smith GE, Ivnik RJ, Tangalos EG, Schaid DJ, Thibodeau SN, Kokmen E, Waring SC, Kurland LT: Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA 1995; 273: 1274-1278.
6. Monacelli AM, Cushman LA, Kavcic V, Duffy CJ: Spatial disorientation in Alzheimer's disease: the remembrance of things passed. Neurology 2003; 61: 1491-1497. (Pubitemid 37505567)
7. Hort J, Laczó J, Vyhnálek M, Bojar M, Bures J, Vlcek K: Spatial navigation deficit in amnestic mild cognitive impairment. Proc Natl Acad Sci USA 2007; 104: 4042-4047. (Pubitemid 47181575)
8. Raber J, Wong D, Buttini M, Orth M, Bellosta S, Pitas RE, Mahley RW, Mucke L: Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females. Proc Natl Acad Sci USA 1998; 95: 10914-10919. (Pubitemid 28413168)
9. Raber J, Wong D, Yu GQ, Buttini M, Mahley RW, Pitas RE, Mucke L: Alzheimer's disease: apolipoprotein E and cognitive performance. Nature 2000; 404: 352-354. (Pubitemid 30164327)
10. Berteau-Pavy F, Park B, Raber J: Effects of sex and APOEε 4 on object recognition and spatial navigation in the elderly. Neuroscience 2007; 147: 6-17. (Pubitemid 46881104)
11. O'Keefe J, Dostrovsky J: The hippocampus as a spatial map: preliminary evidence from unit activity in the freely-moving rat. Brain Res 1971; 34: 171-175.
12. Morris RG, Garrud P, Rawlins JN, O'Keefe J: Place navigation impaired in rats with hippocampal lesions. Nature 1982; 297: 681-683. (Pubitemid 12096189)
13. Laczó J, Andel R, Vyhnalek M, Vlcek K, Magerova H, Varjassyova A, Tolar M, Hort J: Human analogue of the Morris water maze for testing subjects at risk of Alzheimer's disease. Neurodegener Dis 2010; 7: 148-152.
14. Yesavage JA: Geriatric Depression Scale. Psychopharmacol Bull 1988; 24: 709-711.
15. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944. (Pubitemid 14076461)
16. Petersen RC: Mild cognitive impairment as a diagnostic entity. J Intern Med 2004; 256: 183-194. (Pubitemid 39222988)
17. Hixson JE, Vernier DT: Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hha I. J Lipid Res 1990; 31: 545-548. (Pubitemid 20107994)
18. Stepankova K, Pastalkova E, Kalova E, Kalina M, Bures J: A battery of tests for quantitative examination of idiothetic and allothetic place navigation modes in humans. Behav Brain Res 2003; 147: 95-105. (Pubitemid 37491418)
19. Laczó J, Hort J, Vlcek K, Vyhnalek M, Bojar M, Vajnerova O, Holmerova I, Horinek D, Kalina M, Bures J: Spatial memory impairment in Alzheimer's disease is detectable even in patients with mild cognitive impairment. Cesk Slov Neurol N 2006; 102: 431-437. (Pubitemid 46043755)
20. Kalová E, Vlcek K, Jarolímová E, Bures J: Allothetic orientation and sequential ordering of places is impaired in early stages of Alzheimer's disease: corresponding results in real space tests and computer tests. Behav Brain Res 2005; 159: 175-186. (Pubitemid 40462494)
21. Laczó J, Vlcek K, Vyhnálek M, Vajnerová O, Ort M, Holmerová I, Tolar M, Andel R, Bojar M, Hort J: Spatial navigation testing discriminates two types of amnestic mild cognitive impairment. Behav Brain Res 2009; 202: 252-259.
22. Bondi MW, Salmon DP, Galasko D, Thomas RG, Thal LJ: Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer's disease. Psychol Aging 1999; 14: 295-303. (Pubitemid 29291565)
23. Kim KW, Youn JC, Jhoo JH, Lee DY, Lee KU, Lee JH, Woo JI: Apolipoprotein Eε 4 allele is not associated with cognitive impairment in community-dwelling normal elderly individuals. Int J Geriatr Psychiatry 2002; 17: 635-640. (Pubitemid 34784719)
24. Delpolyi AR, Rankin KP, Mucke L, Miller BL, Gorno-Tempini ML: Spatial cognition and the human navigation network in AD and MCI. Neurology 2007; 69: 986-997. (Pubitemid 47366052)
25. Caselli RJ, Graff-Radford NR, Reiman EM, Weaver A, Osborne D, Lucas J, Uecker A, Thibodeau SN: Preclinical memory decline in cognitive normal apolipoprotein E-e4 homozygotes. Neurology 1999; 53: 201-207. (Pubitemid 29329672)
26. Jonker C, Schmand B, Lindeboom J, Havekes LM, Launer LJ: Association between apolipoprotein Eε 4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia. Arch Neurol 1998; 55: 1065-1069. (Pubitemid 28367231)
27. Small BJ, Graves AB, McEvoy CL, Crawford FC, Mullan M, Mortimer JA: Is ApoE-ε 4 a risk factor for cognitive impairment in normal aging? Neurology 2000; 54: 2082-2088. (Pubitemid 30397206)
28. Smith GE, Bohac DL, Waring SC, Kokmen E, Tangalos EG, Ivnik RJ, Petersen RC: Apolipoprotein E genotype influences cognitive 'phenotype' in patients with Alzheimer's disease but not in healthy controls. Neurology 1998; 50: 355-362.
29. Small BJ, Rosnick CB, Fratiglioni L, Bäckman L: Apolipoprotein E and cognitive performance: a meta-analysis. Psychol Aging 2004; 19: 592-600. (Pubitemid 39603405)
30. Greenwood PM, Sunderland T, Friz JL, Parasuraman R: Genetics and visual attention: selective deficits in healthy adult carriers of theε 4 allele of the apolipoprotein E gene. Proc Natl Acad Sci USA 2000; 97: 11661-11666.
31. Parasuraman R, Greenwood PM, Sunderland T: The apolipoprotein E gene, attention, and brain function. Neuropsychology 2002; 16: 254-274. (Pubitemid 34280261)
32. Greenwood PM, Lambert C, Sunderland T, Parasuraman R: Effects of apolipoprotein E genotype on spatial attention, working memory, and their interaction in healthy, middle-aged adults: results from the National Institute of Mental Health's BIOCARD Study. Neuropsychology 2005; 19: 199-211. (Pubitemid 40381656)
33. Wolk DA, Dickerson BC; Alzheimer's Disease Neuroimaging Initiative: Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease. Proc Natl Acad Sci USA 2010; 107: 10256-10261.
34. Van der Vlies AE, Pijnenburg YAL, Koene T, Klein M, Kok A, Scheltens P, van der Flier WM: Cognitive impairment in Alzheimer's disease is modified by APOE genotype. Dement Geriatr Cogn Disord 2007; 24: 98-103. (Pubitemid 47094068)
35. Tierney MC, Szalai JP, Snow WG, Fisher RH, Tsuda T, Chi H, McLachlan DR, St George-Hyslop PH: A prospective study of the clinical utility of ApoE genotype in the prediction of outcome in patients with memory impairment. Neurology 1996; 46: 149-154. (Pubitemid 26156121)
36. Astur RS, Taylor LB, Mamelak AN, Philpott L, Sutherland RJ: Humans with hippocampus damage display severe spatial memory impairments in a virtual Morris water task. Behav Brain Res 2002; 132: 77-84. (Pubitemid 34195461)
37. Feigenbaum JD, Morris RG: Allocentric versus egocentric spatial memory after unilateral temporal lobectomy in humans. Neuropsychology 2004; 18: 462-472. (Pubitemid 38944382)
38. Burgess N, Jeffery KJ, O'Keefe J: The Hippocampal and Parietal Foundations of Spatial Cognition, ed 1. Oxford, Oxford University Press, 1999.
39. Aguirre GK, D'Esposito M: Topographical disorientation: a synthesis and taxonomy. Brain 1999; 122: 1613-1628. (Pubitemid 29425666)
40. Ibánez V, Pietrini P, Alexander GE, Furey ML, Teichberg D, Rajapakse JC, Rapoport SI, Schapiro MB, Horwitz B: Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease. Neurology 1998; 50: 1585-1593. (Pubitemid 28283222)
41. Rossor MN, Kennedy AM, Frackowiak RS: Clinical and neuroimaging features of familial Alzheimer's disease. Ann NY Acad Sci 1996; 777: 49-56. (Pubitemid 26149169)
42. Small GW, Ercoli LM, Silverman DH, Huang SC, Komo S, Bookheimer SY, Lavretsky H, Miller K, Siddarth P, Rasgon NL, Mazziotta JC, Saxena S, Wu HM, Mega MS, Cummings JL, Saunders AM, Pericak-Vance MA, Roses AD, Barrio JR, Phelps ME: Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc Natl Acad Sci USA 2000; 97: 6037-6042. (Pubitemid 30367519)
43. Rapoport SI: Functional brain imaging to identify affected subjects genetically at risk for Alzheimer's disease. Proc Natl Acad Sci USA 2000; 97: 5690-5698.